Skip to main content
. 2022 Nov 3;10(1):502–517. doi: 10.1002/ehf2.14208

Table 2.

Performance (AUC) of the different risk prediction tools for all‐cause mortality and readmission

Cohort 28 day mortality 3 month mortality 1 year mortality 28 day readmission 3 month readmission 1 year readmission
ADHERE 0.758 (0.671–0.845) 0.768 (0.689–0.847) 0.757 (0.681–0.833) 0.609 (0.558–0.659) 0.599 (0.570–0.628) 0.568 (0.542–0.593)
GWTG‐HF 0.767 (0.677–0.856) 0.772 (0.691–0.854) 0.762 (0.684–0.840) 0.640 (0.594–0.696) 0.608 (0.579–0.637) 0.569 (0.543–0.594)
ASCEND 0.833 (0.775–0.891) 0.827 (0.771–0.884) 0.802 (0.742–0.862) 0.655 (0.609–0.701) 0.614 (0.586–0.643) 0.580 (0.555–0.605)
GISSI‐HF 0.839 (0.781–0.896) 0.831 (0.777–0.885) 0.822 (0.768–0.876) 0.661 (0.616–0.705) 0.623 (0.594–0.651) 0.598 (0.573–0.622)
SHFM 0.794 (0.724–0.864) 0.790 (0.725–0.856) 0.787 (0.725–0.849) 0.680 (0.637–0.723) 0.636 (0.608–0.663) 0.608 (0.583–0.633)
MAGGIC‐HF 0.850 (0.786–0.915) 0.836 (0.774–0.897) 0.819 (0.756–0.883) 0.660 (0.616–0.705) 0.623 (0.595–0.651) 0.602 (0.577–0.627)
BCN‐Bio‐HF 0.838 (0.785–0.891) 0.828 (0.777–0.879) 0.812 (0.758–0.865) 0.680 (0.636–0.724) 0.620 (0.593–0.648) 0.598 (0.573–0.623)

ADHERE, the Acute Decompensated Heart Failure National Registry model; ASCEND, Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure risk scores; AUC, area under the receiver operating characteristic curve; BCN‐Bio‐HF, Barcelona Bio‐Heart Failure risk calculator; GISSI‐HF, Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico‐Heart Failure; GWTG‐HF, Get With the Guidelines‐Heart Failure programme; MAGGIC‐HF, Meta‐Analysis Global Group in Chronic Heart Failure risk score; SHFM, Seattle Heart Failure Model.